The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...
CareDx (CDNA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
CareDx is estimated to be 35% overvalued based on current share price of US$14.35 Our fair value estimate is 51% lower than CareDx's analyst price target of US$21.83 Today we'll do a simple run ...
Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...
CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...
H.C. Wainwright analyst Yi Chen reiterated a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $22.93. Chen covers the Healthcare sector, focusing on ...
Trump Media and Technology Group (“Trump Media,” Nasdaq/NYSE Texas: DJT) announced that Truth Social will embed federally ...
Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback